Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2026
Debiopharm unveils pre-clinical results for MultiLINK ADC linker technologies at World ADC 2026
Swiss-based biopharmaceutical company Debiopharm announced pre-clinical proof-of-concept research on its MultiLINK Linker Technology suite (MLINK Select, MLINK Duo, MLINK HiSol), presented at World ADC 2026 in San Diego. Results showed broadening of the therapeutic index for vedotin-based ADCs with MLINK Select, synergistic antitumor activity for dual-payload MLINK Duo ADCs, and MLINK HiSol's potential to enable targeted small-molecule inhibitor payloads.
2020
Oncomfort completes €10 million Series A funding round
Oncomfort announced the completion of a €10 million Series A funding round co-led by Debiopharm and Crédit Mutuel Innovation. The company said it planned to use the investment to develop its digital therapy solutions and accelerate international expansion.
2020
Novadiscovery closes first €5 million of Series A funding
Novadiscovery closed the first €5 million of a planned €7 million Series A funding round, with Debiopharm leading the investment.